Regeneron Pharmaceuticals
(REGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 95,229 | 118,285 | 80,077 | 247,393 | 30,978 |
| Marketable Securities | 200,753 | 175,489 | 184,194 | 137,686 | 86,634 |
| Receivables | 43,102 | 15,529 | 4,017 | 2,975 | 13,835 |
| Inventories | 3,229 | 9,006 | 6,831 | 3,973 | 1,915 |
| TOTAL | $343,955 | $320,207 | $276,948 | $394,186 | $134,142 |
| Non-Current Assets | |||||
| PPE Net | 71,239 | 80,723 | 76,825 | 39,448 | 36,934 |
| Investments And Advances | 52,930 | 72,792 | 30,975 | 53,304 | 37,025 |
| Other Non-Current Assets | 4,984 | 5,833 | 6,826 | 8,459 | 173 |
| TOTAL | $129,153 | $159,348 | $114,626 | $101,211 | $74,132 |
| Total Assets | $473,108 | $479,555 | $391,574 | $495,397 | $208,274 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 18,872 | 18,933 | 30,309 | 14,830 | 9,446 |
| TOTAL | $34,139 | $72,923 | $40,118 | $22,022 | $13,786 |
| Non-Current Liabilities | |||||
| Long Term Debt | 200,000 | 200,000 | 200,000 | 200,000 | 1,466 |
| Deferred Revenues | 15,267 | 40,173 | 9,659 | 6,766 | 3,728 |
| Other Non-Current Liabilities | 0 | 159 | 0 | 0 | 294 |
| TOTAL | $256,426 | $268,989 | $205,475 | $207,020 | $12,358 |
| Total Liabilities | $290,565 | $341,912 | $245,593 | $229,042 | $26,144 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 56,122 | 55,563 | 44,503 | 43,964 | N/A |
| Common Shares | 56 | 55 | 44 | 44 | 37 |
| Retained earnings | -489,834 | -531,533 | -424,075 | -299,698 | -223,518 |
| Other shareholders' equity | -3,068 | -3,997 | -3,172 | -1,615 | -780 |
| TOTAL | $182,543 | $137,643 | $145,981 | $266,355 | $182,130 |
| Total Liabilities And Equity | $473,108 | $479,555 | $391,574 | $495,397 | $208,274 |